BusinessIGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis-Based, Combination TherapiesBy Nasdaq OMXMay 16, 2017, 1:58 PM UTC
BusinessIGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis-Based, Combination TherapiesBy Nasdaq OMXMay 16, 2017, 1:58 PM UTC
BusinessIGC Files International Patents for IGC-501 Compound Indicated for Neuropathic PainBy Nasdaq OMXApr 10, 2017, 10:00 AM UTC
BusinessIGC Files Patent for Cannabis-based Combination Therapy for Treatment of Eating DisordersBy Nasdaq OMXMar 21, 2017, 12:03 PM UTC
BusinessIGC Files Patent for Cannabis-based Combination Therapy for Treatment of Eating DisordersBy Nasdaq OMXMar 21, 2017, 12:03 PM UTC
BusinessIGC Files Patent for Cannabis-based Combination Therapy for Treatment of Eating DisordersBy Nasdaq OMXMar 21, 2017, 12:03 PM UTC
BusinessIGC Files Patent for Cannabis-based Combination Therapy for Treatment of Eating DisordersBy Nasdaq OMXMar 21, 2017, 12:03 PM UTC
